|
Issue dtd. 16th to 31st August 2005
INSIDE
COVER STORY
FOCUS
INTERVIEW
EVENTS
PLANNING
PHARMA
CONFERENCE WATCH
LETTERS
RURAL HEALTHCARE
PRODUCTS
CONVERSATION
SUPPLEMENTS
CRITICARE
LABWATCH
HOSPIUPDATE

ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US


 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Exp. Hotelier & Caterer
  Exp. Travel & Tourism
  Exp. Pharma Pulse
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

Untitled Document
 

 

-
Home > Planning
Planning

Adverse drug reaction programme in a multispeciality hospital
Because of a rapid increase in the list of newer drugs launched in the market in the last few decades; adverse drug reaction monitoring of these drugs has assumed prime importance. Since India is a country, which caters to the maximum number of human population for the final assessment of drug safety as a part of post marketing surveillance studies, it becomes necessary to report any untoward reaction of any pharmaceutical product.

Back to Top

© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.